TARGET National: A UK-wide Liquid-based Molecular Profiling Programme: On Behalf of the TARGET National Consortium

Affiliations

¹ The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
² Translational and Clinical Research Institute, NU Cancer, Newcastle University, Newcastle upon Tyne, UK; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
³ The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: matthew.krebs@manchester.ac.uk.

Editorial

A Ortega-Franco et al. Clin Oncol (R Coll Radiol). 2023 Jan.

. 2023 Jan;35(1):33-37.

doi: 10.1016/j.clon.2022.10.005. Epub 2022 Nov 2.

¹ The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
² Translational and Clinical Research Institute, NU Cancer, Newcastle University, Newcastle upon Tyne, UK; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
³ The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: matthew.krebs@manchester.ac.uk.

No abstract available

Keywords: Early phase clinical trial; Genomic profiling; Liquid biopsy; Precision medicine; Targeted therapy; ctDNA.

Publication types